Literature DB >> 21008077

Mutational dysostosis (cleidocranial dysostosis).

A B SOULE.   

Abstract

Entities:  

Keywords:  BONES/growth

Mesh：

Year:  1946        PMID： 21008077

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN： 0021-9355            Impact factor:   5.284


× No keyword cloud information.
  7 in total

1.  Searching for additional endocrine functions of the skeleton: genetic approaches and implications for therapeutics.

Authors:  Jianwen Wei; Stephen Flaherty; Gerard Karsenty
Journal:  Expert Rev Endocrinol Metab       Date:  2015-06-16

2.  Cleidocranial dysostosis. A report of three cases.

Authors:  P L Nawalkha; M N Saxena; P Sharda; D C Sharda
Journal:  Indian J Pediatr       Date:  1969-05       Impact factor: 1.967

3.  A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development.

Authors:  P Ducy; M Starbuck; M Priemel; J Shen; G Pinero; V Geoffroy; M Amling; G Karsenty
Journal:  Genes Dev       Date:  1999-04-15       Impact factor: 11.361

4.  Cleidocranial dysostosis, hereditary haemorrhagic telangiectasia and epilepsy: a rare association.

Authors:  B M Tress; I F Mosely
Journal:  Neuroradiology       Date:  1977       Impact factor: 2.804

5.  Cleidocranial dysostosis in infancy.

Authors:  K L Tan; L K Tan
Journal:  Pediatr Radiol       Date:  1981

6.  Maternal and offspring pools of osteocalcin influence brain development and functions.

Authors:  Franck Oury; Lori Khrimian; Christine A Denny; Antoine Gardin; Alexandre Chamouni; Nick Goeden; Yung-yu Huang; Hojoon Lee; Prashanth Srinivas; Xiao-Bing Gao; Shigetomo Suyama; Thomas Langer; John J Mann; Tamas L Horvath; Alexandre Bonnin; Gerard Karsenty
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

7.  Modulation of cognition and anxiety-like behavior by bone remodeling.

Authors:  Lori Khrimian; Arnaud Obri; Gerard Karsenty
Journal:  Mol Metab       Date:  2017-10-06       Impact factor: 7.422
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.